ATE533774T1 - Neuartige nukleosidanaloge zur behandlung von virusinfektionen - Google Patents

Neuartige nukleosidanaloge zur behandlung von virusinfektionen

Info

Publication number
ATE533774T1
ATE533774T1 AT08708805T AT08708805T ATE533774T1 AT E533774 T1 ATE533774 T1 AT E533774T1 AT 08708805 T AT08708805 T AT 08708805T AT 08708805 T AT08708805 T AT 08708805T AT E533774 T1 ATE533774 T1 AT E533774T1
Authority
AT
Austria
Prior art keywords
treatment
virus infections
nucleoside analogues
novel nucleoside
novel
Prior art date
Application number
AT08708805T
Other languages
German (de)
English (en)
Inventor
Zheng Yin
Jeyaraj Duraiswamy
Yen Chen
Original Assignee
Novartis Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39462074&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE533774(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Pharma Ag filed Critical Novartis Pharma Ag
Application granted granted Critical
Publication of ATE533774T1 publication Critical patent/ATE533774T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT08708805T 2007-02-09 2008-02-07 Neuartige nukleosidanaloge zur behandlung von virusinfektionen ATE533774T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07102027 2007-02-09
EP08150003 2008-01-02
PCT/EP2008/051527 WO2008095993A1 (en) 2007-02-09 2008-02-07 Novel nucleoside analogs for treatment of viral infections

Publications (1)

Publication Number Publication Date
ATE533774T1 true ATE533774T1 (de) 2011-12-15

Family

ID=39462074

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08708805T ATE533774T1 (de) 2007-02-09 2008-02-07 Neuartige nukleosidanaloge zur behandlung von virusinfektionen

Country Status (18)

Country Link
US (1) US8278282B2 (OSRAM)
EP (1) EP2132216B1 (OSRAM)
JP (1) JP2010518047A (OSRAM)
KR (1) KR20090109102A (OSRAM)
CN (1) CN101600726B (OSRAM)
AR (1) AR065249A1 (OSRAM)
AT (1) ATE533774T1 (OSRAM)
AU (1) AU2008212752A1 (OSRAM)
BR (1) BRPI0807222A2 (OSRAM)
CA (1) CA2675462A1 (OSRAM)
CL (1) CL2008000409A1 (OSRAM)
EA (1) EA200901080A1 (OSRAM)
ES (1) ES2381093T3 (OSRAM)
MX (1) MX2009008495A (OSRAM)
PE (1) PE20090070A1 (OSRAM)
PT (1) PT2132216E (OSRAM)
TW (1) TW200838550A (OSRAM)
WO (1) WO2008095993A1 (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010015643A1 (en) * 2008-08-06 2010-02-11 Novartis Ag New antiviral modified nucleosides
CN102526087B (zh) * 2010-12-30 2014-09-03 南开大学 核苷类化合物在制备治疗肠病毒71(ev71)感染疾病药物的应用
CN105669783B (zh) * 2014-12-03 2019-11-12 广东东阳光药业有限公司 一种制备呋喃糖的方法
JP2018523665A (ja) 2015-08-06 2018-08-23 キメリックス インコーポレイテッド 抗ウイルス剤として有用なピロロピリミジンヌクレオシドおよびその類縁体
RU2720811C2 (ru) 2015-09-23 2020-05-13 Мерк Шарп И Доум Лимитед 4'-замещенные нуклеозидные ингибиторы обратной транскриптазы и их получение
EA201892448A1 (ru) * 2016-04-28 2019-06-28 Эмори Юниверсити Алкинсодержащие нуклеотидные и нуклеозидные терапевтические композиции и связанные с ними способы применения
TW201815821A (zh) * 2016-07-18 2018-05-01 美商再生元醫藥公司 抗茲卡病毒抗體及使用方法
TW201811339A (zh) * 2016-08-12 2018-04-01 美商艾洛斯生物製藥公司 經取代之核苷、核苷酸及其類似物
EP3684771B1 (en) 2017-09-21 2024-11-27 Chimerix, Inc. Morphic forms of 4-amino-7-(3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-methyl-7h-pyrrolo(2,3-d)pyrimidine-5-carboxamide and uses thereof
US11718534B2 (en) 2019-04-23 2023-08-08 Elementis Specialties, Inc. Slurry compositions containing mixed branched alkyl organoclay compositions
US20250057849A1 (en) * 2021-12-22 2025-02-20 Cj Cheiljedang Corporation Antiviral composition comprising nucleoside analogues derived from nucleic acid and pharmaceutically acceptable salt thereof
CN117430571B (zh) * 2022-07-15 2025-08-29 宜昌东阳光长江药业股份有限公司 一种制备吡喃葡萄糖基衍生物的关键中间体及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0206614A (pt) * 2001-01-22 2004-02-17 Merck & Co Inc Composto, composição farmacêutica, método para inibir a polimerase viral de rna dependente de rna e/ou inibir a replicação viral de rna dependente de rna, método para tratar uma infecção viral de rna dependente de rna, e, uso de um composto
JP2005511764A (ja) * 2001-12-14 2005-04-28 アルコン，インコーポレイテッド 緑内障の処置のためのアミノアルキルベンゾフラン−５−オール化合物
JP2005527499A (ja) * 2002-02-13 2005-09-15 メルク　エンド　カムパニー　インコーポレーテッド ヌクレオシド化合物を用いてオルトポックスウイルスの複製を阻害する方法
MXPA04010983A (es) * 2002-05-06 2005-02-14 Genelabs Tech Inc Derivados de nucleosidos para tratar infecciones por el virus de la hepatitis c.
TW200418498A (en) * 2002-09-30 2004-10-01 Genelabs Tech Inc Nucleoside derivatives for treating hepatitis C virus infection
US20040259934A1 (en) * 2003-05-01 2004-12-23 Olsen David B. Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compounds
WO2005042556A1 (en) * 2003-10-27 2005-05-12 Genelabs Technologies, Inc. Nucleoside compounds for treating viral infections

Also Published As

Publication number Publication date
CA2675462A1 (en) 2008-08-14
CL2008000409A1 (es) 2008-08-29
ES2381093T3 (es) 2012-05-23
PE20090070A1 (es) 2009-03-19
WO2008095993A1 (en) 2008-08-14
AU2008212752A1 (en) 2008-08-14
BRPI0807222A2 (pt) 2014-04-29
JP2010518047A (ja) 2010-05-27
US20100227833A1 (en) 2010-09-09
CN101600726A (zh) 2009-12-09
EP2132216A1 (en) 2009-12-16
EP2132216B1 (en) 2011-11-16
AR065249A1 (es) 2009-05-27
MX2009008495A (es) 2009-08-20
PT2132216E (pt) 2012-02-20
KR20090109102A (ko) 2009-10-19
US8278282B2 (en) 2012-10-02
TW200838550A (en) 2008-10-01
CN101600726B (zh) 2013-03-27
EA200901080A1 (ru) 2010-02-26

Similar Documents

Publication Publication Date Title
ATE533774T1 (de) Neuartige nukleosidanaloge zur behandlung von virusinfektionen
SMT201600325B (it) Alifani, ciclofani, eterafani, eterofani, etero-eterafani e metalloceni sostituiti utili per il trattamento di infezioni da hcv
ZA201008215B (en) Small molecule inhibitors for the treatment or prevention of dengue virus infection
ATE434620T1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
ATE541845T1 (de) 2,3-substituierte azaindolderivate zur behandlung von virusinfektionen
DE202012013074U8 (de) Zusammensetzungen zur Behandlung von HCV
EP2135858A4 (en) COMPOSITION FOR TREATING INFECTIOUS DISEASES
PL3354276T3 (pl) Kompozycje do leczenia zapalenia przewodu pokarmowego
ATE550329T1 (de) Heterobicyclische sulfonamidderivate zur behandlung von diabetes
EP2081593A4 (en) LIVE BACTERIAL VACCINES FOR PROPHYLAXIS OR TREATMENT OF VIRAL INFECTION
DK2982696T3 (da) Behandling af akut lymfoblastær leukæmi
EP1755661A4 (en) USE OF GELSOLINE FOR THE TREATMENT OF INFECTIONS
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
EP2021352A4 (en) TREATMENT OF POOR FOLDING OF PROTEINS
BRPI0718548A2 (pt) Estabilização de vacinas por liofilização
EP2101785A4 (en) TREATMENT OF IT SEC
ATE527241T1 (de) Pyridiazinonderivate zur behandlung von tumoren
EP2254582A4 (en) METHOD FOR THE TREATMENT OF VIRUS INFECTIONS
ATE532507T1 (de) Neramexane zur behandlung von subakuten tinnitus
EP2010184A4 (en) IMPLANTS FOR THE TREATMENT OF DOPAMINE-ASSOCIATED CONDITIONS
ATE429218T1 (de) Pinolensäure zur behandlung von übergewicht
DK2249866T3 (da) Anvendelse af et acetylsalicylsyresalt til behandlingen af virusinfektioner
ATE493986T1 (de) Diarylharnstoffe zur behandlung von pulmonaler hypertonie
EP2249765A4 (en) DAPSONE TO TREAT THE ROSACEA
EP2210621A4 (en) COMPOSITION FOR TREATING JOINT DISEASE

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2132216

Country of ref document: EP